Introduction
The term prediabetes or "intermediate hyperglycaemia" is a strong risk factor of diabetes mellitus. The criteria for diagnosis of prediabetes includes impaired fasting glucose (IFG) [fasting plasma glucose (FPG) of 6.1-6.9 mmol/L (110 to 125 mg/dL)] and impaired glucose tolerance (IGT) [2 h plasma glucose of 7.8-11.0 mmol/L (140-200 mg/dL) after ingestion of 75 g of oral glucose] (1). It is a transit stage from where a person can revert back to normal or develop into diabetes. The risk for develop into diabetes of 5%-10% in a year and more than 25% in 3-5 year (2) . More than 470 million people will have in prediabetes stage till 2030 (3) . Prediabetes is may related with the insulin resistance and β-cell dysfunction. Prediabetics are more prone to develop Type-2 Diabetes mellitus and related macro-microvascular complications (4) . Ayurveda, the science of life, described prameha which is considered equivalent to different stage of diabetes. Different Ayurvedic texts classify it into two broad categories viz. Sahaja Prameha and Apathyanimittaja Prameha (5) . The description of Apathyanimittaja Prameha has very much similarity with Prediabetes/Type-2 Diabetes mellitus. Obesity is one of the important risk factor for DM. The relation of obesity and DM is described by the Sthula Pramehi. For Sthula Pramehi Ayurveda advocates Apatarpana approach for their management (6) . The Ayurvedic management of any disease includes samshamana (pacify the vitiated dosha in body) and samshodhana (biopurification procedures) therapy (7) . In the present study a samshodhana procedure was adopted for prediabetic patient was Vamana (therapeutic vomiting) procedure by herbal drugs. Aims and objectives 1.
To evaluate the effect of Vamana Karma on subjective and objectives parameters in Prediabetics patients.
2.
To established Vamana Karma as preventive and/or curative measures in Prediabetics.
Materials and Methods

Selection of cases
A total of 60 cases of Prediabetics were selected from Outdoor Patient Department and Indoor Patient Department of Kayachikitsa, Sir Sunder Hospital, Institute of Medical Sciences, Banaras Hindu University, Varanasi. All the patients were examined thoroughly according to predefined format before including into study. Ethical approval from institutional ethical committee, I.M.S., B.H.U. was obtained prior to commencement of study.
Inclusion criteria
Patients between 30-60 yrs. age with positive family history of DM, hypertension and Dyslipidemia were registered in the study. These patients have fasting plasma glucose and postprandial level of 100-125 mg/dL and 140-199 mg/dL respectively with HbA 1 C ranging 5.7-6.4.
Exclusion criteria
While patients less than 30yrs. and more than 60yrs, previous diagnosed as type I or type II DM with or without complications, endocrinopathies induced diabetes (phaeochromocytoma, acromegaly, cushing's syndrome, hyperthyroidism etc.) and drug/chemical (glucocorticoids, thyroid hormone, thiazides, phenytoin etc.) induced DM excluded from study. Moreover certain genetic syndromes associated with diabetes mellitus e.g. Down's syndrome, Turner's syndrome, Klinefelter's syndrome etc. also not registered in study.
Study design
Out of 60 registered patients, 10 patients were dropped out (7 patients from Group-I and 3 patients from Group-II) in course of study. Group I (n= 30) patients were advised for Vamana therapy by Madanaphala Yoga. Group II (Control group, n=30) patients were treated with modern drug (Metformin, 500 mg, O.D.) (8) .
Vamana Karma
The total procedure of vamana was divided into three phase viz. purva karma (initial phase), mukhya karma (main phase of vamana) and pachatya karma (Samsarjana karma) (5, 6) .
Purva karma (initial phase)
The patients were subjected to snehapana with Go-Ghrita (30 mL) in the morning (approx. 7:00 AM) on empty stomach. The dose of grita was increase by 30 mL/day according to strength of patient. The patients were advised to take only lukewarm water and light meal when he/she feels hunger. The light diet may include wheat Chapati with vegetables or Dala day time and Khichadi in evening. After proper Snehana, 30 mins Abhyanga (massage) with Narayana taila followed by 30 min Vashpa Sveda (steam bath) was given to the patients on alternate days twice a day [morning (at about 10 am) and evening (at about 4.30 pm)]. Further patients were advised to take rest for 15 min on the chair and then after move on bed covered with blanket and not to move in open area. Kapha Vardhaka (Krishara type) articles were administered by the patients on the evening of gap day. The Krishara (Khichadi) was made with 50-50 g rice, Masha (Urada Dala), 25-25 g of Taila, Ghrita and 250 g of curd as well as salt according to taste.
Vamana Karma
Main procedure of Vamana was perform with madanphaladi yoga (containing Madanphala, Vacha Churna, Madhu and Saindhava mixed in the quantity of 6 gms, 2 gms, 20 gms and 1.5 gms respectively) per oral. 200 mL milk was provided to the patient 5 min before the madanphaladi yoga administration. After 10 min of drug administration milk was again provided as much as patient can drink. The emesis started within 10 min and during the Vamana Vega the patient was assist by a attendant which presses his/her abdomen with palms as well as provide gentle massage in upwards direction.
Presence of Pitta in vomitus was considered as end point of procedure. 2 L lukeworm saline water was used to induce emesis. After emesis patient was transfer in a fumigated room and put under observation for one day.
Samsarjana karma
The emesis was categories into three phases Pravara, Madhyama & Avara on the basis of symptoms after emesis. Depend upon type of emesis specific samsarjana krama was adopted for individual patient accordinf to their appetite. Different recopies such as Peya, Vilepi, Mudga Yusha and rice with Mudga Yusha were given once, twice and thrice in a day for Pravara, Madhyama & Avara emesis respectively from the evening of Vamana day for 3, 5 & 7 days respectively. All the patients were advised to continue their normal diet and life style after samsarjana karma.
Assessment criteria
Both subjective and objective parameters were used to assess the effect of the treatment on subjects. 
ii. Objective Assessment
Objective assessment includes BMI (body mass index), fasting blood glucose and postprandial blood glucose level.
Results
The study shows the incidence of age and sex of 60 patients of Prediabetes revealed that the registered patients were fall in the age range between 30 to 60 years. The sex incidence in 60 cases, the greater number of patients were male i.e. 42 (70.00%) followed by female 18 (30.00%).
Clinical Symptomatology
Incidence of clinical symptomatology in 60 patients of Prediabetes revealed that in Group-I, the maximum number of patients (90%) had Laziness followed by Polyurea (66.6%), Polyphagia (63.4%), dryness in mouth (63.3%), Polydipsia (56.6), Burning sensation (53.3%), Excessive Sleep (50%), Excessive Sweating (46.7%), Flabbiness (33.3%), Liking of Cold things (20%), and Numbness (3.3%). In Group-II, Incidence of clinical symptomatology in 60 patients of Prediabetes revealed that the maximum number of patients (73.4%) had Laziness followed by Polyurea & Polyphagia (60%), Dryness in mouth (53.4%), Polydipsia / Burning sensation / Excessive Sleep (50%), Excessive Sweating (33.3%), Flabbiness (30%), Liking of Cold things (13.3%) and Numbness (6.7%) ( Table 1) . 
Effect of trial treatment on clinical symptomatology of prediabetes
The study shows the significant shift of grades of Polyurea in different trial groups (Table 2) , Table 6 ). (Table 7) . (Table 9 ). On Flabbiness, shift of grade was statistically highly significant (p<0.001, χ 2 =22.082) in Group-II, while it was statistically significant (p<0.05, χ 2 =10.500) in Group-I (Table 10) . On Dryness in mouth, the study shows the significant shift of grades in different trial groups, it was statistically highly significant (p<0.001, χ 2 =28.653) in Group-I and also statistically highly significant (p<0.001, χ 2 =23.041) in Group-II (Table 11) . On the basis of Chi-square Test, between the Group comparison, the differences were statistically not significant (p>0.05) in any group.
Effect of trial treatment on laboratory parameters BMI:
The BMI study shows that the initial mean and SD for Group-I was 26.67±2.978 which decreased to 25.71±3.119 after trial treatment; the result was statistically highly significant (p<0.001). In Group-II mean was decreased from 24.63±2.194 to 24.53±1.768 showing statistically insignificant result (p>0.05). The difference in means was highest in Group-I (1.056) followed by Group-II (0.146) (Table 13 ). --
Fasting Blood Sugar
The blood sugar fasting in Group-I, the initial mean + S.D. was 112.03 ± 8.28 which reduced to 98.22 ± 11.917 after complete follow-up, the improvement was statistically highly significant (p<0.001). While in Group-II, the initial mean + SD 112.60 ± 8.253 reduced to 100.03 ± 10.979, this fall was also statistically highly significant (p<0.001). The reduction in means was highest in Group-I (12.848) followed by Group-II (12.233) (Table 14) . 
Postprandial Blood Sugar
The postprandial blood sugar estimations in Group-I, the initial mean + S.D. was 174.54 ± 15.535 which decreased to 140.37 ± 13.85 after 3 rd follow-up, the reduction was statistically highly significant (p<0.001). While in Group-II, the initial mean + SD was 175.32 ± 15.295 decreased to 143.33 ± 17.136, it was also statistically highly significant (p < 0.001). The difference in means was highest in Group-I (34.943) followed by Group-II (31.856) (Table 15) . 
Mean percentage fall in FBS & PPBS in different trial group
The Group-I (Vamana Karma Group) shows maximum fall (11.47%) in fasting blood sugar level followed by Group-II (Control Group) (10.86%). The rate of fall in postprandial blood sugar in Group-I was maximum (20.02%) followed by Group-II (18.17%) (Table 16 ). 
